Samantha I Cunningham1, Yonggang Shi2, James D Weiland3, Paulo Falabella4, Lisa C Olmos de Koo3, David N Zacks5, Bosco S Tjan6. 1. Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA. 2. Laboratory of Neuro Imaging, USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. 3. USC Eye Institute, University of Southern California, Los Angeles, CA, USA. 4. USC Eye Institute, University of Southern California, Los Angeles, CA, USA ; Department of Ophthalmology and Visual Sciences, Federal University of São Paulo, São Paulo, Brazil. 5. Kellogg Eye Center, University of Michigan, Ann Arbor, MI, USA. 6. Neuroscience Graduate Program, University of Southern California, Los Angeles, CA, USA ; Department of Psychology, University of Southern California, Los Angeles, CA, USA.
Abstract
PURPOSE: Magnetic resonance imaging (MRI) can measure the effects of vision loss and recovery on brain function and structure. In this case study, we sought to determine the feasibility of acquiring anatomical and functional MRI data in recipients of the Argus II epiretinal prosthesis system. METHODS: Following successful implantation with the Argus II device, two retinitis pigmentosa (RP) patients completed MRI scans with their implant unpowered to measure primary visual cortex (V1) functional responses to a tactile task, whole-brain morphometry, V1 cortical thickness, and diffusion properties of the optic tract and optic radiation. Measurements in the subjects with the Argus II implant were compared to measurements obtained previously from RP patients and sighted individuals. RESULTS: The presence of the Argus II implant resulted in artifacts that were localized around the patient's implanted eye and did not extend into cortical regions or white matter tracts associated with the visual system. Structural data on V1 cortical thickness and the retinofugal tract obtained from the two Argus II subjects fell within the ranges of sighted and RP groups. When compared to the RP and sighted subjects, Argus II patients' tactile-evoked cross-modal functional MRI (fMRI) blood oxygen level-dependent (BOLD) responses in V1 also fell within the range of either sighted or RP groups, apparently depending on time since implantation. CONCLUSIONS: This study demonstrates that successful acquisition and quantification of structural and functional MR images are feasible in the presence of the inactive implant and provides preliminary information on functional changes in the brain that may follow sight restoration treatments. TRANSITIONAL RELEVANCE: Successful MRI and fMRI acquisition in Argus II recipients demonstrates feasibility of using MRI to study the effect of retinal prosthesis use on brain structure and function.
PURPOSE: Magnetic resonance imaging (MRI) can measure the effects of vision loss and recovery on brain function and structure. In this case study, we sought to determine the feasibility of acquiring anatomical and functional MRI data in recipients of the Argus II epiretinal prosthesis system. METHODS: Following successful implantation with the Argus II device, two retinitis pigmentosa (RP) patients completed MRI scans with their implant unpowered to measure primary visual cortex (V1) functional responses to a tactile task, whole-brain morphometry, V1 cortical thickness, and diffusion properties of the optic tract and optic radiation. Measurements in the subjects with the Argus II implant were compared to measurements obtained previously from RP patients and sighted individuals. RESULTS: The presence of the Argus II implant resulted in artifacts that were localized around the patient's implanted eye and did not extend into cortical regions or white matter tracts associated with the visual system. Structural data on V1 cortical thickness and the retinofugal tract obtained from the two Argus II subjects fell within the ranges of sighted and RP groups. When compared to the RP and sighted subjects, Argus II patients' tactile-evoked cross-modal functional MRI (fMRI) blood oxygen level-dependent (BOLD) responses in V1 also fell within the range of either sighted or RP groups, apparently depending on time since implantation. CONCLUSIONS: This study demonstrates that successful acquisition and quantification of structural and functional MR images are feasible in the presence of the inactive implant and provides preliminary information on functional changes in the brain that may follow sight restoration treatments. TRANSITIONAL RELEVANCE: Successful MRI and fMRI acquisition in Argus II recipients demonstrates feasibility of using MRI to study the effect of retinal prosthesis use on brain structure and function.
Authors: Ione Fine; Alex R Wade; Alyssa A Brewer; Michael G May; Daniel F Goodman; Geoffrey M Boynton; Brian A Wandell; Donald I A MacLeod Journal: Nat Neurosci Date: 2003-09 Impact factor: 24.884
Authors: James D Weiland; Boozarjomehr Faraji; Robert J Greenberg; Mark S Humayun; Frank G Shellock Journal: Magn Reson Imaging Date: 2012-01-20 Impact factor: 2.546
Authors: Samantha I Cunningham; James D Weiland; Pinglei Bao; Gilberto Raul Lopez-Jaime; Bosco S Tjan Journal: Vision Res Date: 2014-11-03 Impact factor: 1.886
Authors: Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith Journal: Neuroimage Date: 2011-09-16 Impact factor: 6.556
Authors: Eberhart Zrenner; Karl Ulrich Bartz-Schmidt; Heval Benav; Dorothea Besch; Anna Bruckmann; Veit-Peter Gabel; Florian Gekeler; Udo Greppmaier; Alex Harscher; Steffen Kibbel; Johannes Koch; Akos Kusnyerik; Tobias Peters; Katarina Stingl; Helmut Sachs; Alfred Stett; Peter Szurman; Barbara Wilhelm; Robert Wilke Journal: Proc Biol Sci Date: 2010-11-03 Impact factor: 5.349